動物用狂犬病ワクチンの世界市場：市場規模・シェア・動向分析 (用途別・地域別)、セグメント別予測 (2025年～2030年)

動物用狂犬病ワクチン市場の成長と動向：

Grand View Research社の最新レポートによると、世界の動物用狂犬病ワクチンの市場規模は2030年までに11億米ドルに達する見込みです。

同市場は2025年から2030年にかけてCAGR 5.9%で拡大すると予測されています。市場を牽引する主な要因としては、人獣共通感染症に対する意識の高まり、迷子動物への予防接種率の向上、2030年までに狂犬病を根絶することを目的とした政府の取り組みの増加などが挙げられます。動物の狂犬病予防接種市場を促進する主な要因の1つは、家畜用ワクチンに対する認識と教育です。家畜種への使用が承認されているワクチンは数多くあり、不活化ウイルスベクター製品、改変型ウイルスベクター製品、IM注射用製品、SC注射用製品、接種期間が1～3年の製品、最低接種年齢の製品などがあります。定期的な公衆教育、責任あるペットの飼育、獣医による定期的な治療とワクチン接種、継続的な専門家によるトレーニングは、狂犬病の予防と制御にとって極めて重要な要素です。狂犬病の感染経路に関する知識を広めることで、野生動物との接触を避け、餌となる狂犬病ワクチンを野生動物に接種する必要性が広く浸透し、野生動物からの感染拡大を抑えることに大きく役立っています。さらに、ワクチン接種によって家畜の一般的な健康状態が改善され、全死因死亡率の低下にもつながっています。

狂犬病は中枢神経系を攻撃する致死的な病気で、臨床症状が現れると有効な治療法はないです。世界中で犬の狂犬病に860万米ドルが費やされていると推定され、毎年発生する狂犬病による総死亡者数約6万人の98%を占めています。米国は過去50年間、動物および人間の集団における狂犬病を根絶するために多大な努力を払ってきました。イヌを媒介とする狂犬病に感染する動物の数は、動物の集団予防接種方法の開発と放し飼い規制の実施により、年間最大1万件から減少しました。このような動きにもかかわらず、狂犬病は依然として公衆衛生に大きな脅威を与え続けており、米国全土の野生動物貯蔵庫のアライグマ、スカンク、キツネで流行しています。

世界中で、COVID-19の大流行が重要な保健サービスを混乱させています。「ワンヘルス」戦略を提唱する狂犬病対策連合フォーラムは、この目標の達成を早めるために2020年に設立されました。世界狂犬病戦略の主な構成要素には、地域社会の関与、ヒト用狂犬病ワクチンへのアクセスの改善、犬の集団予防接種の拡大などが含まれます。狂犬病撲滅戦略の進展は、十分な医療を受けられない人々の医療アクセスの公平性を示す指標として、また「ワンヘルス」の成功の早期指標として用いることができます。世界の狂犬病撲滅戦略の中核をなすのは、犬の集団予防接種であり、その接種率は70%を目標としています。大半の流行国では、犬用ワクチンの流通、数量削減、輸入の遅れといった困難が見られました。これは当初、犬用ワクチンが必要品目の範疇に入らなかったためです。ザンビアのように現地で製造されている国でも、予算の制限により犬用ワクチンの製造ができませんでした。

狂犬病は唾液を介して感染するため、感染した動物に噛まれることで感染します。狂犬病はサル、犬、コウモリ、場合によっては猫から感染します。インドネシアにおける狂犬病患者の98%は、狂犬病に感染した犬に噛まれたことが原因です。国立医学図書館が2021年12月に発表した論文によると、過去10年間で、動物の狂犬病患者数は世界的にわずかに増加しています。タイでは2017年から2018年にかけて、動物狂犬病の特徴を明らかにし、一般化加法モデルを用いて毎月の狂犬病発生率と理解しやすい要因との関係を評価し、狂犬病蔓延の地理的リスク地域を推定する研究が実施されました。調査によると、タイでは犬が狂犬病に感染する最も一般的な動物種です。感染犬の大多数は飼い犬であり、自由に歩き回っており、ワクチン接種を受けていませんでした。狂犬病の感染者が最も集中しているのは東北地方であり、次いで中南部地方です。短期的には、症例数は6月以降徐々に増加し、2018年は1月から大幅に増加しました。このような狂犬病流行国では、犬の集団予防接種プログラム、野生動物のエサとなる狂犬病ワクチン接種キャンペーン、ペットの狂犬病ワクチン接種の義務化など、強力な対策が講じられており、市場の成長を後押しすると予想されます。

動物用狂犬病ワクチン市場レポートハイライト

• コンパニオンアニマル分野は、いくつかの国で規制されているペット狂犬病ワクチン接種の義務化、主に実施されている犬の集団ワクチン接種プログラム、犬の飼育率の大幅な上昇により、2024年に最大の収益シェアを占めました。
• 野生動物分野は、先進地域での野生動物用狂犬病ワクチン接種キャンペーンの高まりにより、予測期間中最も速いCAGR 4%で拡大すると予測されます。
• 北米は予測期間中もリードを維持すると予想されます。これは、この地域の一人当たりの動物医療費が高く、ペットの飼育率が高いためです。米国のほぼすべての州では、近い将来に狂犬病を根絶するという使命のもと、ペットへの定期的な狂犬病ワクチン接種を義務付けています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 動物用狂犬病ワクチン市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 動物用狂犬病ワクチン市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
• 規制の枠組み
• 価格分析
• COVID-19の影響分析

第4章 動物用狂犬病ワクチン市場：用途別の推定・動向分析

• セグメントダッシュボード
• 動物用狂犬病ワクチン市場：変動分析、用途別
• 動物用狂犬病ワクチンの展望：用途別
• 市場規模の予測と動向分析 (2018～2030年)
• コンパニオンアニマル
• 家畜
• 野生動物

第5章 動物用狂犬病ワクチン市場：流通チャネル別の推定・動向分析

• セグメントダッシュボード
• 動物用狂犬病ワクチン市場：変動分析、流通チャネル別
• 動物用狂犬病ワクチンの展望：流通チャネル別
• 市場規模の予測と動向分析 (2018～2030年)
• 小売業
• eコマース
• 病院・クリニック薬局

第6章 動物用狂犬病ワクチン市場：地域別の推定・動向分析

• 地域別のダッシュボード
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • デンマーク
  • ノルウェー
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート
  • その他中東・アフリカ

第7章 競合情勢

• 企業分類
• 最新動向と影響分析：主要な市場参入企業別
• 市場シェア分析、企業別 (2024年)
• 企業概要
  • Boehringer Ingelheim International GmbH
  • Zoetis Services LLC
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Virbac
  • BiogenesisBago
  • Elanco
  • Ceva
  • BroadChem Philippines Biopharma Corporation
• 戦略マッピング
  • 企業合併・買収 (M&A)
  • パートナーシップとコラボレーション
  • 拡張
  • その他
• その他の主要企業のリスト

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 4. Global Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 5. Global Rabies Veterinary Vaccines market, by Region, 2018 - 2030 (USD Million)
• Table 6. North America Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
• Table 7. North America Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 8. North America Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 9. U.S. Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 10. U.S. Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 11. Canada Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 12. Canada Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 13. Mexico Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 14. Mexico Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 15. Europe Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
• Table 16. Europe Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 17. Europe Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 18. UK Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 19. UK Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 20. Germany Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 21. Germany Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 22. France Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 23. France Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 24. Italy Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 25. Italy Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 26. Spain Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 27. Spain Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 28. Sweden Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 29. Sweden Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 30. Denmark Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 31. Denmark Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 32. Norway Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 33. Norway Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 34. Rest of Europe Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
• Table 35. Rest of Europe Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 36. Asia Pacific Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 37. Asia Pacific Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 38. Japan Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 39. Japan Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 40. China Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 41. China Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 42. India Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 43. India Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 44. Australia Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 45. Australia Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 46. South Korea Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 47. South Korea Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 48. Thailand Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 49. Thailand Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 50. Rest of Asia Pacific Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 51. Rest of Asia Pacific Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 52. Latin America Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 53. Latin America Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 54. Brazil Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 55. Brazil Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 56. Argentina Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 57. Argentina Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 58. Rest of LA Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 59. Rest of LA Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 60. Middle East and Africa Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
• Table 61. Middle East and Africa Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 62. Middle East and Africa Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 63. South Africa Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 64. South Africa Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 65. Saudi Arabia Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 66. Saudi Arabia Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 67. UAE Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 68. UAE Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 69. Kuwait Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 70. Kuwait Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 71. Rest of MEA Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
• Table 72. Rest of MEA Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Rabies Veterinary Vaccines market, Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Global Rabies Veterinary Vaccines market, for Application, 2018 - 2030 (USD Million)
• Fig. 15 Global Rabies Veterinary Vaccines market, for Companion Animals, 2018 - 2030 (USD Million)
• Fig. 16 Global Rabies Veterinary Vaccines market, for Livestock Animals, 2018 - 2030 (USD Million)
• Fig. 17 Global Rabies Veterinary Vaccines market, for Wildlife Animals, 2018 - 2030 (USD Million)
• Fig. 18 Global Rabies Veterinary Vaccines market, for Distribution Channel, 2018 - 2030 (USD Million)
• Fig. 19 Global Rabies Veterinary Vaccines market, for Retail, 2018 - 2030 (USD Million)
• Fig. 20 Global Rabies Veterinary Vaccines market, for E-Commerce, 2018 - 2030 (USD Million)
• Fig. 21 Global Rabies Veterinary Vaccines market, for Hospital/Clinic Pharmacies, 2018 - 2030 (USD Million)
• Fig. 22 Regional Outlook, 2024 & 2030
• Fig. 23 North America Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 24 US Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 25 Canada Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 26 Mexico Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 27 Europe Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 28 UK Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 29 Germany Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 30 France Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 31 Italy Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 32 Spain Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 33 Sweden Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 34 Denmark Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 35 Norway Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 36 Rest of Europe Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 37 Asia Pacific Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 38 Japan Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 39 China Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 40 India Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 41 Australia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 42 South Korea Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 43 Thailand Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 44 Rest of Asia Pacific Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 45 Latin America Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 46 Brazil Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 47 Argentina Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 48 Rest of LA Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 49 Middle East and Africa Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 50 South Africa Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 51 Saudi Arabia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 52 UAE Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 53 Kuwait Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
• Fig. 54 Rest of MEA Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)

Rabies Veterinary Vaccines Market Growth & Trends:

The global rabies veterinary vaccines market size is expected to reach USD 1.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2025 to 2030. The key factors driving the market include an increase in zoonotic disease awareness, boosting stray animal immunization coverage, and growing number of government initiatives with the motive of eradicating rabies by 2030. One of the main drivers propelling the market for animal rabies vaccinations is domestic animal vaccine awareness and education. There are numerous vaccines approved for use in domestic animal species, which include inactivated and modified-live virus vector products, products for IM and SC injection, products with immunization durations ranging from 1 to 3 years, and products with a range of minimum vaccination ages. Regular public education, responsible pet ownership, routine veterinary treatment and vaccinations, and continuous professional training are crucial elements of rabies prevention and control. By spreading knowledge about rabies transmission channels, the necessity of avoiding contact with wildlife and vaccinating wildlife with bait rabies vaccines are widely initiated, which greatly helps in reducing the spread of the disease from wildlife sources. Additionally, the vaccination improves domestic animals' general health and is linked to a decline in all-cause mortality rates.

Rabies is a deadly disease that attacks the central nervous system and has no effective treatment once clinical signs appear. It is estimated that 8.6 million dollars are spent globally on canine rabies, which is responsible for 98% of approximately 60,000 total rabies deaths that occur each year. The U.S. has made enormous efforts over the past 50 years to eradicate rabies in both animal and human populations. The number of animals infected with canine-mediated rabies has decreased from up to 10,000 cases per year because of the development of mass animal vaccination procedures and the enforcement of leash restrictions. Despite these developments, rabies continues to pose a major threat to public health and is still prevalent in raccoons, skunks, and foxes in wildlife reservoirs throughout the U.S.

All around the world, the COVID-19 pandemic has disrupted crucial health services. The United Against Rabies Forum, which advocates a 'One Health' strategy, was established in 2020 to hasten the achievement of this objective. The main components of the global rabies strategy include community involvement, better access to human rabies vaccines, and expanded mass dog vaccination. The advancement of rabies eradication strategies can be used as a marker for the equity of healthcare access in underserved populations and as an early indicator for the successful implementation of 'One Health'. The core element of the global rabies elimination strategy is mass dog vaccination, with a 70% coverage rate as the goal. The majority of endemic nations saw difficulties with distribution, volume reductions, and importation delays for dog vaccines. This was because dog vaccines initially did not fit within the category of necessary items. Budget restrictions prevented the production of dog vaccines even in countries such as Zambia where they are made locally.

Rabies is spread through saliva, which means the infection can be transmitted through infected animal bites. Rabies can be transmitted by monkeys, dogs, bats, or, in some cases, cats. 98% of rabies cases in Indonesia are caused by rabid dog bites. According to an article published in December 2021, by the National Library of Medicine over the past 10 years, there has been a slight increase in the number of animal rabies cases globally. In Thailand, a study was conducted between 2017 and 2018 to identify the characteristics of animal rabies, assess the relationship between monthly rabies incidence and understandable factors using generalized additive models, and estimate the geographical risk areas for rabies spread. According to the study, dogs are the most common species in Thailand that are infected by rabies. The majority of the infected dogs were owned, roaming freely, and were not vaccinated. The northeast region of the country has the highest concentrations of rabies cases, followed by the middle and southern regions. In the short term, the number of cases increased gradually after June and significantly from January in 2018. Such rabies-endemic countries are taking strong measures such as dog mass vaccination programs, wildlife bait rabies vaccination campaigns, and mandatory pet rabies vaccinations among others, which are anticipated to fuel the growth of the market.

Rabies Veterinary Vaccines Market Report Highlights:

• The companion animals segment held the largest revenue share in 2024 owing to the mandatory pet rabies vaccinations regulated in several countries, largely conducted mass dog vaccination programs, and significantly rising dog ownership rates
• The wildlife animals segment is anticipated to expand at the fastest CAGR of 4% over the forecast period owing to the rising wildlife rabies vaccination campaigns in developed regions
• North America is expected to maintain its lead over the forecast period. This is due to the region's high per capita animal healthcare spending and a large number of pet ownership rates. Almost every state in the U.S. mandates regular rabies vaccination for pets with the mission of eradicating rabies in the near future

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Vaccine Type
  • 1.2.3. Disease type
  • 1.2.4. Route of Administration
  • 1.2.5. Distribution Channel
  • 1.2.6. Regional Scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Rabies Veterinary VaccinesVariables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising animal rabies vaccination coverage in developing countries
    • 3.2.1.2. Increasing concerns over zoonotic diseases
    • 3.2.1.3. Implementation of mass dog vaccination campaigns in various countries
    • 3.2.1.4. Initiatives by market participants
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited access to veterinary services in under developed countries
• 3.3. Rabies Veterinary VaccinesAnalysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
    • 3.3.2.7. Estimated Animal Population by key Species, key Country, 2018-2024
• 3.4. Regulatory Framework
• 3.5. Pricing Analysis
• 3.6. COVID-19 impact Analysis

Chapter 4. Rabies Veterinary Vaccines market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Rabies Veterinary Vaccines market: Application Movement Analysis
• 4.3. Rabies Veterinary Vaccinesby Application Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Companion Animals
  • 4.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.6. Livestock Animals
  • 4.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.7. Wildlife Animals
  • 4.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5. Rabies Veterinary Vaccines market: Distribution Channel Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Rabies Veterinary Vaccines market: Distribution Channel Movement Analysis
• 5.3. Rabies Veterinary Vaccinesby Distribution Channel Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Retail
  • 5.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.6. E-Commerce
  • 5.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.7. Hospital/Clinic Pharmacies
  • 5.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6. Rabies Veterinary Vaccines market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Canada market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. UK market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Germany market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. France market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Italy market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Spain market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4.6. Sweden
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4.7. Denmark
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Norway market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4.9. Rest of Europe
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Rest of Europe market estimates and forecasts 2018 to 2030, (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Japan market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. China market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. India market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Australia market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.7. Rest of Asia-Pacific
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Rest of Asia-Pacific market estimates and forecasts 2018 to 2030, (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.3. Rest of LA
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Rest of LA market estimates and forecasts 2018 to 2030, (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. UAE market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.5. Rest of MEA
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Rest of MEA market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Recent Developments & Impact Analysis by Key Market Participants
• 7.3. Company Market Share Analysis, 2024
• 7.4. Company overview
  • 7.4.1. Boehringer Ingelheim International GmbH
    • 7.4.1.1. Company Overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Zoetis Services LLC
    • 7.4.2.1. Company Overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Indian Immunologicals Ltd.
    • 7.4.3.1. Company Overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Merck & Co., Inc.
    • 7.4.4.1. Company Overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Virbac
    • 7.4.5.1. Company Overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. BiogenesisBago
    • 7.4.6.1. Company Overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Elanco
    • 7.4.7.1. Company Overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Ceva
    • 7.4.8.1. Company Overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. BroadChem Philippines Biopharma Corporation
    • 7.4.9.1. Company Overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
• 7.5. Strategy Mapping
  • 7.5.1. Mergers & Acquisitions
  • 7.5.2. Partnerships & Collaborations
  • 7.5.3. Expansions
  • 7.5.4. Others
• 7.6. List of Other Key Players